AdaptHealth Corp.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.2B | $3.3B | $3.2B | $3.0B | $2.5B |
| Cost of revenue | $2.6B | $2.6B | $2.6B | $2.4B | $2.0B |
| Operating income | $90.9M | $263.7M | -$598.4M | $190.4M | $225.6M |
| Interest expense | — | — | $130.3M | $109.4M | $95.2M |
| Pretax income | -$15.2M | $136.0M | -$723.8M | $97.9M | $191.0M |
| Income tax expense | $50.9M | $41.2M | -$49.0M | $24.8M | $32.8M |
| Net income | -$70.8M | $90.4M | -$678.9M | $69.3M | $156.2M |
| Balance Sheet | |||||
| Current assets | $728.9M | $755.8M | $649.0M | $585.3M | $670.1M |
| Total assets | $4.3B | $4.5B | $4.5B | $5.2B | $5.3B |
| Current liabilities | $712.4M | $567.0M | $537.0M | $456.2M | $499.8M |
| Total liabilities | $2.8B | $2.9B | $3.0B | $3.1B | $3.2B |
| Total debt | $1.8B | $2.0B | $2.2B | $2.2B | $2.2B |
| Stockholders' equity | $1.5B | $1.6B | $1.5B | $2.2B | $2.1B |
| Cash Flow Statement | |||||
| Cash from operations | $601.8M | $541.8M | $480.7M | $373.9M | $275.7M |
| Depreciation and amortization | $381.9M | $365.3M | $382.8M | $351.2M | $258.1M |
| Stock-based compensation | $21.9M | $14.9M | $22.5M | $22.4M | $25.3M |
| Capital expenditure | $382.4M | $306.1M | $337.5M | $391.4M | $203.3M |
| Free cash flow | $219.4M | $235.8M | $143.2M | -$17.6M | $72.4M |
| Share repurchases | $0 | $0 | $29.3M | $14.0M | $0 |
| Impairments | $1.2M | $2.7M | $830.8M | $800,000 | $0 |
Shares outstanding 136.1M · Free float 48.7%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.